SV Health Investors aims to transform healthcare through investments in diverse entrepreneurs who create and build breakthrough companies and treatments. They operate across three main sectors: Therapeutics, Healthcare Growth, and Medtech, seeking innovative breakthroughs with the power to change therapeutic paradigms and supporting industry leaders transforming healthcare with growth capital and liquidity. The firm strongly adheres to the view that diversity, including under-represented groups, strongly adds to success and seeks to partner with entrepreneurs to build their businesses. The firm has a dedicated Dementia Discovery Fund (DDF) which focuses specifically on companies developing novel therapies for dementia. They invest in a broad range of therapeutic modalities and technologies in the dementia space. Their approach involves providing not only capital but also strategic support to help portfolio companies navigate the complexities of the healthcare industry and achieve their growth objectives. They look for compelling teams and technologies with the potential to significantly impact patient lives and improve healthcare outcomes. SV Health Investors values partnerships with talented innovators and is committed to supporting them through the various stages of company development. They appear to take a long-term perspective, investing in companies with the potential for sustained growth and impact on healthcare.
Preferred startup development maturity for initial funding deployment.
Therapeutics, Healthcare Growth, Medtech, Dementia
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...